Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Kenya

 

Is the profit motive at odds with impact investing goals in emerging market healthcare?

Last week Bloomberg accused US private equity firm TPG of putting profit before the interest of patients in various emerging market hospitals it has invested in. We spoke to TPG to get their response to the specific accusations made against them. We also spoke to others operating in Africa about whether there is, at a more general level, a tension between seeking profit whilst simultaneously seeking to achieve impact investing goals in emerging market healthcare. 
September 4, 2025

How the Medical Credit Fund and PharmAccess are enhancing healthcare access and infrastructure in Sub-Saharan Africa — and what Europe can learn from Africa

Healthcare systems around the world are increasingly overstretched, fragmented, and facing growing disease burdens and rising costs. While established markets such as Europe grapple with demographic shifts and rising demand within mature but strained systems, Sub-Saharan Africa (SSA) is confronting the urgent need to build infrastructure and scale healthcare provision to serve a growing population. […]
January 31, 2025

UK tightens foreign recruitment visas

This week, the UK’s Home Secretary James Cleverly announced government plans to tighten health and care worker visas. HBI speaks to a global workforce expert to understand what this attempt to prioritise ‘British talent first’ will mean for operators already facing a workforce crisis.
December 8, 2023

Kenyan healthcare continues to attract overseas investor interest

Global private equity firm Alta Semper is injecting millions into MYDAWA, a primary and digital healthcare platform based in Kenya. It aims to solidify the group’s position as a key player in developing Africa’s healthcare industry at a time when Kenya is attracting a lot of interest from overseas investors.
October 13, 2023

Fresenius to sell Curalie after De Meo’s discreet departure

Fresenius’ digital health subsidiary Curalie is reportedly up for sale, as the conglomerate’s CEO continues to win over investors, streamline the group, and replace management. Meanwhile HBI hears former Helios CEO Francesco De Meo may be unhappy with the circumstances of his departure - and could seek legal advice.
September 22, 2023

Helios CEO Francesco De Meo leaves with little fanfare

Fresenius Helios has a new CEO. Germany’s largest hospital group by revenue and subsidiary of Germany-based conglomerate Fresenius announced the news in a press release which ignores outgoing Francesco De Meo’s significant and longstanding contribution to the group.
September 15, 2023

Fighting back against brain drain

Western Europe is becoming increasingly dependent on importing talent to address its workforce crisis, but there are signs of resistance to the brain drain. With Nigeria looking to introduce a mandatory domestic five-year service for all doctors, HBI speaks to a global workforce expert to see if this kind of pushback could have any lasting impact.
May 26, 2023
Older posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us